Cohen Veterans Bioscience announced findings from a study which generates new evidence in support of a critical brain imaging biomarker, that may help guide people who suffer from post-traumatic stress disorder (PTSD) or major depressive disorder (MDD) towards the most effective treatment. We’re honored to sponsor and participate in NAVREF’s Annual Conference 2020. We look forward to sharing our innovations from the frontlines of Veterans brain research. Our team members will be presenting on advancing precision therapeutics and policy efforts to improve Veterans brain health.RECENT NEWS
Help us fast-track diagnostics and treatments for Post-Traumatic Stress Disorder (PTSD) & Traumatic Brain Injury (TBI).
We Need Precision Medicine for The Brain
We bring together the brightest minds and deploy the most innovative scientific tools with an emphasis on scale, risk-minimization, efficiency and speed.
Recent Highlights
News
New Study Reveals Brain Circuit Biomarkers to Predict Response to Treatment in Patients with Complex Neuropsychiatric Disorders
Events
NAVREF Annual Conference – September 14-16, 2020
Donate Now
